BeStock  
Stocks › Biotechnology › DNA

Ginkgo Bioworks DNA

US equityMarket cap rank #3607BiotechnologyAI medical concept stocks
$7.46 −$0.74 (-9.02%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.55 +1.21%
Open$7.93
Prev close$8.20
Day range$7.38 – $8.29
Volume2.51M
Market cap$483.59M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership64.3%-1.81 pts vs. prior quarter
Institutions holding209-11 vs. prior quarter
Insider trades (recent)18 buys / 32 sellsNet selling
Short interest14.09% of floatDays to cover 3.9 · as of 30 Oct 2026
Short-sale volume share21.9%5-day average of daily volume

Short-sale volume as % of daily volume

10%17%24%31%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$3.72M (10 inflow days, 10 outflow days).

Net flow by order size, last 20 sessions

+$792.0KSuper+$2.9MBig+$377.2KMid+$885.5KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 25.4% of shares outstanding.

Largest holders

  • BlackRock6.97%
  • Viking Global Investors LP5.52%
  • Cascade Investment, L.L.C.5.13%
  • Erste Asset Management GmbH3.91%
  • Reshma Shetty3.86%
  • Bartholomew Canton3.71%
  • Baillie Gifford3.69%
  • Austin Che3.68%

By investor type

  • Mutual Fund38.82%
  • Individual/Insider15.30%
  • Hedge Fund14.37%
  • Family Office/Trust5.14%
  • Public Company3.26%
  • VC/PE Fund1.17%
  • Private Company0.94%
  • Insurance Company0.33%

Reported short interest has risen from 8.31% to 14.09% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Acadian Asset Management LLC Mutual Fund 2026/Q3 +588,118 1.4%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +519,770 2.2%
Barclays PLC Public Company 2026/Q3 +485,289 0.8%
BlackRock Mutual Fund 2026/Q3 +236,232 7.0%
Franklin Resources Mutual Fund 2026/Q3 +151,425 0.3%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +120,721 0.7%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +97,197 1.0%
State Street Global Advisors Mutual Fund 2026/Q3 +96,365 2.4%
Winton Capital Group Limited Hedge Fund 2026/Q3 +69,149 0.1%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +140,485 0.2%
BlackRock Mutual Fund 2026/Q3 +640,556 6.4%
Erste Asset Management GmbH Mutual Fund 2026/Q3 +589,211 3.8%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +439,400 0.8%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +372,151 1.4%
AQR Capital Management Hedge Fund 2026/Q3 +327,492 0.9%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
18 Oct 2026 Jason Kelly Co-Founder, Co-COO, CEO & Director Intent to Sell (Form 144) -45,682 $10.14 –
18 Oct 2026 Reshma Shetty Co-Founder & President Intent to Sell (Form 144) -22,369 $10.14 –
18 Oct 2026 Austin Che Co-Founder & Head of Strategy Intent to Sell (Form 144) -16,058 $10.14 –
18 Oct 2026 Austin Che Co-Founder & Head of Strategy Intent to Sell (Form 144) -2,200 $10.38 –
18 Oct 2026 Bartholomew Canton Chief Technology Officer Intent to Sell (Form 144) -18,803 $10.14 –
18 Oct 2026 Steven Coen Chief Financial Officer Intent to Sell (Form 144) -766 $10.14 –
18 Oct 2026 Jason Kelly Co-Founder, Co-COO, CEO & Director Derivative Exercise and Sale -45,682 $10.14 129,065
18 Oct 2026 Reshma Shetty Co-Founder & President Derivative Exercise and Sale -22,369 $10.14 453,951
18 Oct 2026 Bartholomew Canton Chief Technology Officer Derivative Exercise and Sale -18,803 $10.14 356,329
18 Oct 2026 Steven Coen Chief Financial Officer Derivative Exercise and Sale -766 $10.14 50,168
15 Oct 2026 Jason Kelly Co-Founder, Co-COO, CEO & Director Derivative Exercise and Retained +35,802 – 129,065
15 Oct 2026 Reshma Shetty Co-Founder & President Derivative Exercise and Retained +17,529 – 453,951
15 Oct 2026 Bartholomew Canton Chief Technology Officer Derivative Exercise and Retained +17,761 – 356,329
15 Oct 2026 Steven Coen Chief Financial Officer Derivative Exercise and Retained +720 – 50,168
4 Oct 2026 Steven Coen Chief Financial Officer Automatic Disposition -2,403 $15.00 49,448
4 Oct 2026 Steven Coen Chief Accounting Officer Intent to Sell (Form 144) -2,403 $15.00 –
16 Sep 2026 Austin Che Co-Founder & Head of Strategy Intent to Sell (Form 144) -2,200 $7.29 –
14 Sep 2026 Christian O. Henry Independent Director Open Market Disposition -5,000 $7.08 19,310
23 Aug 2026 Steven Coen Chief Financial Officer Intent to Sell (Form 144) -330 $6.98 –
23 Aug 2026 Steven Coen Chief Financial Officer Derivative Exercise and Sale -330 $6.98 51,851

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 9,490,310 14.1% 3.9
15 Oct 2026 8,294,322 12.3% 1.9
30 Sep 2026 7,315,221 10.9% 2.7
15 Sep 2026 7,166,128 10.6% 7.2
31 Aug 2026 6,865,017 10.2% 5.5
14 Aug 2026 5,596,447 8.3% 4.3

Discussion

No comments yet — be the first to weigh in on DNA.

Sign in to join the discussion.

Scroll to Top